Skip to nav Skip to content

News Releases and Statements

Facebook Twitter LinkedIn Email

IDSA and HIVMA Call for Greater U.S. Leadership in Accelerating Global Vaccine Equity

IDSA and its HIVMA support the Biden Administration’s call for new global commitments to control the COVID-19 pandemic and applaud the Administration’s initial steps of donating vaccine doses and making financial contributions to COVAX, the COVID-19 Vaccines Global Access initiative. 

IDSA Response to Federal Response to Antimicrobial Resistance

IDSA is encouraged by today’s announcement from the Biden Administration on the allocation of more than $2 billion of American Rescue Plan funds to support infection prevention and efforts to combat antimicrobial resistance.

IDSA Submits Comments on Joint Commission’s Antibiotic Stewardship Requirements

IDSA has expressed support for several proposed revisions to The Joint Commission’s antibiotic stewardship requirements for hospitals, while also providing additional recommendations to ensure the changes align with the Society’s strategic priorities.

Statement on President Biden’s Covid Response Strategy

IDSA supports President Biden’s multi-pronged approach to  boost vaccination rates and strengthen our COVID-19 response. With COVID-19 cases on the rise and health systems stretched to capacity, it is imperative to public health and safety that eligible people get vaccinated.

Infectious Diseases Experts Call for Layered Strategy to Protect Students and School Employees

IDSA is urging school systems nationwide to use all available public health tools and strategies to prevent COVID-19 transmission in schools as teachers and students return to in-person learning.

IDSA Response to Full FDA Approval of the Pfizer-BioNTech COVID-19 Vaccine

The FDA’s full approval of the Pfizer-BioNTech COVID-19 vaccine marks a pivotal milestone in the nation’s quest to control the effects of this pandemic. This approval is the culmination of intense, collaborative scientific research. The FDA’s announcement gives people who have not yet taken the vaccine additional assurance that this vaccine is safe and effective. 

Response to Plan for Supplemental Vaccine Doses for Vaccinated Individuals

IDSA appreciates that HHS is planning to provide vaccinated people with a supplemental dose of vaccines if the FDA and CDC recommend a supplemental dose following a thorough and transparent evaluation of the evidence.

Statement on FDA Authorization of Supplemental Vaccine Dose for Immunocompromised Patients

IDSA supports the FDA and CDC’s decision to authorize a supplemental vaccine dose for immunocompromised patients. This authorization will provide more protection for those who are at risk of serious COVID-19 illness and disease.

New OFID Article Explores How to Address Vaccine Confidence in Black, Indigenous and Other People of Color During the COVID-19 Pandemic

Increasing confidence in COVID-19 vaccines and uptake in these communities requires a creative, flexible and nimble approach that addresses the diverse concerns and barriers to vaccine access that people may have, according to a new article in Open Forum Infectious Diseases.

Statement of Strong Medical Consensus for Vaccination of Pregnant Individuals Against COVID-19

Pregnant individuals and those planning to become pregnant should feel confident in choosing vaccination to protect themselves, their infants, their families, and their communities.

Clinical Infectious Diseases Publishes “COVID Transmission in Homes, Hospitals and the Community” Supplement

A new Clinical Infectious Diseases supplement collects eight papers that have informed the scientific underpinning of essential nonbiological interventions used in the public health response to COVID-19.

Infectious Diseases Professionals: Eliminating Viral Hepatitis ‘Ambitious but Achievable’ Goal

As scientific and political leaders commemorate World Hepatitis Day, infectious diseases professionals  call on policymakers to support the updated National Viral Hepatitis Strategic Plan that aims to eliminate viral hepatitis as a public health threat in the United States.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.